Who invested in TB Biosciences?
TB Biosciences's investors include Ben Franklin Technology Partners, Originate Ventures and NYU Innovation Venture Fund.
United States · Series A startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$1.5Mraised across 1 round since 2013, from 1 source
Reported by finsmes.comSEC filing: $1.3M sold, first sale May 2013
TB Biosciences's investors include Ben Franklin Technology Partners, Originate Ventures and NYU Innovation Venture Fund.
TB Biosciences has raised $1.5M across 1 round since 2013.
TB Biosciences's most recent round was a Series A of $1.5M in Jul 2013.
Its most recent round, $1.5M in Jul 2013, is also its largest on record.
TB Biosciences's first round on record, in Jul 2013, was backed by Ben Franklin Technology Partners, Originate Ventures and NYU Innovation Venture Fund.
TB Biosciences's latest named round is a Series A, in Jul 2013.
TB Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.